Khairy: Malaysia to shorten AstraZeneca dosing interval from 12 to nine weeks


PUTRAJAYA: Malaysia will shorten the dosing interval for AstraZeneca vaccine recipients to nine weeks from 12 weeks, says Khairy Jamaluddin.

The National Covid-19 Immunisation Programme coordinating minister said this was the recommendation made to the Special Committee on Covid-19 Vaccine Supply (JKJAV) by its technical working group.

“Those who participated in the first round of AstraZeneca (opt-in programme) will be notified of their appointment soon,” said Khairy in a Twitter post on Thursday (July 1).

Based on the recommendation from our Technical Working Group & with greater clarity of the delivery schedule, @JKJAVMY has decided to shorten the dosing interval for AZ from 12 to nine weeks. Those who participated in the first round of AZ will be notified of their 2nd appt soon.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Saifuddin to consult lawyers over reduction of Zuraida's fine
Bill to establish Malaysian Ombudsman body to be drafted soon, says Kulasegaran
Teacher claims trial to sexual offences against 12yo pupil
Kulai motorcyclist killed after crashing into divider trying to avoid lorry
60,000 aid scheme slots still open to flood-hit padi farmers, Dewan Rakyat told
Cabinet agrees in principle to cooperate with Vietnam to explore maritime resources, says Home Minister
M'sia to boost border security with tech, rather than building walls, says Home Minister
Saifuddin also claims Dr M acted alone in Batu Puteh decision
Floods: Slight rise in number of evacuees in T'ganu, Pahang
Malaysia needs digital innovation to become high-income nation, says PM

Others Also Read